Showing 581-590 of 1836 results for "".
DermWireTV: Atopic Dermatitis Pipeline Watch, a Potential New Skin Cancer Treatment; Demystifying Itch, and the Premiere of PA Perspectives
https://practicaldermatology.com/topics/practice-management/dermwiretv-atopic-dermatitis-pipeline-watch-a-potential-new-skin-cancer-treatment-demystifying-itch-and-the-premiere-of-pa-perspectives/20228/Escient Pharmaceuticals, Rapt Therapeutics, and Connect Biopharma each report positive results from early clinical studies in AD. Finnish researchers discover a potential treatment for cutaneous squamous cell carcinoma in an existing chemotherapy drug. Research out of Harvard Medical School links ecDermWireTV: Diversity in Dermatology; Inclusive Beauty Initiatives; Eczema Awareness Month
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-diversity-in-dermatology-inclusive-beauty-initiatives-eczema-awareness-month/20152/La Roche-Posay and the Women's Dermatologic Society have partnered to sponsor a Fellowship in the Department of Dermatology at Howard University's College of Medicine for Underrepresented in medicine medical students. WDS President Mona Gohara, MD shares insights about the need to support DEI in derSkin Cancer Perceptions, Cimzia for Psoriasis, Eczema and CV Risk
https://practicaldermatology.com/topics/psoriasis/dermwire-tv-skin-cancer-perceptions-cimzia-for-psoriasis-eczema-and-cv-risk/18301/A new national survey, Skin Cancer In America 2018, conducted by Health Union, explores perceptions of patients with skin cancer. Cimzia (certolizumab pegol, UCB) has received FDA approval for treatment of adults with moderate to severe plaque psoriasis. Cimzia is the first Fc-free, PEGylated anti TAmerican Academy of Dermatology 2024
Meeting Wrap-Uphttps://practicaldermatology.com/cme/dermatology/meeting-coverage-aad-2024/24461/Practical Dermatology® was at the American Academy of Dermatology 2024 Annual Meeting in San Diego (AAD 2024) reporting on the latest research findings on innovative therapies and insights into managing complex dermatological disorders. From pioneering trials showcasing the efficacy of novel topicalDr. Garden Discusses Experience with the VariLite Laser
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/dr-garden-discusses-experience-with-gemini-laser/19467/"The VariLite system is a wonderful choice for those people who want to enter into the laser arena. Because many, many patients have vessels which naturally occur as they grow older or especially those who develop rosacea later in life, this is something that many practices have the need for treatPearls for Monitoring and Managing Itch: An Expert Panel
https://practicaldermatology.com/topics/atopic-dermatitis/pearls-for-monitoring-and-managing-itch-an-expert-panel/27172/A three-person panel covered the topic of itch recently at The Dermatology Education Foundation’s DEF Essential Resource Meeting 2024 (DERM2024) NP/PA CME Conference in Las Vegas, Nevada, with David Cohen, MD, MPH, leading “How to Avoid Doctor Strange: Pearls for Monitoring and Managing Itch.” Dr. CDermWireTV: Medicare Cuts; Revision, Alastin, Obagi Acquisitions; CSF Hits Nashville
https://practicaldermatology.com/topics/practice-management/dermwiretv-medicare-cuts-revision-alastin-obagi-acquisitions-csf-hits-nashville/20033/Congress is working to avert a potential pay cut for physicians who treat Medicare patients, and a bipartisan solution has been introduced. Cuts loom as the AMA has released data showing that Medicare claims data exclusive to physician services fell an estimated $13.9 billion or 14 percent below expExpanded Options in Adjuvant Immunotherapy for Resectable Melanoma: A Multidisciplinary Conversation
https://practicaldermatology.com/programs/cme/expanded-options-in-adjuvant-immunotherapy-for-resectable-melanoma-a-multidisciplinary-conversation/18065/Tune in to learn best practices for using adjuvant systemic therapy and appropriate agents for stage IIB-IV resectable melanoma patients.Sunscreen Ratings, Restylane Lyft for Hands, NPF, SCF News
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-sunscreen-ratings-restylane-lyft-for-hands-npf-scf-news/18305/Both Consumer Reports and the Environmental Working Group have issued sunscreen rankings, and while some products shine, many products may underperform. FDA issued warnings to several companies illegally marketing dietary supplements that make unproven drug claims about protecting consumers from sunHumphries to Valeant, Restylane Line Expands, 2016 Highlights
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-humphries-to-valeant-restylane-line-expands-2016-highlights/18709/The filler market in the US expands with FDA approval of Galderma's Restylane Refyne and Restalyne Define for the treatment of nasolabial folds in patients over the age of 21. The gels are manufactured with XpresHAn Technology, which allows a range of flexibility and support for varied patient needs